These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis]. Zierski M Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101 [No Abstract] [Full Text] [Related]
33. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
34. Drug-resistant tuberculosis in Cuba. Results of the three global projects. Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512 [TBL] [Abstract][Full Text] [Related]
35. Isoniazid resistant TB and non-compliance. van Altena R; van Soolingen D; van der Werf TS Thorax; 2004 Dec; 59(12):1098; author reply 1098-9. PubMed ID: 15563712 [No Abstract] [Full Text] [Related]
36. New generation methods for drug susceptibility testing for tuberculosis. Katoch VM Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820 [No Abstract] [Full Text] [Related]
37. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia. Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255 [TBL] [Abstract][Full Text] [Related]
38. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? Gupta R; Raviglione MC; Espinal MA Int J Tuberc Lung Dis; 2001 Dec; 5(12):1078-9. PubMed ID: 11769764 [No Abstract] [Full Text] [Related]
39. Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy. Escudero E; Peña JM; Alvarez-Sala R; Vázquez JJ; Ortega A Int J Tuberc Lung Dis; 2006 Apr; 10(4):409-14. PubMed ID: 16602405 [TBL] [Abstract][Full Text] [Related]
40. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]